Tilmicosin 30% oral solution
Tilmicosin Solution is a broadspectrum semisynthetic bactericidal macrolide antibiotic synthesized from
tylosin.Tilmicosin Solutionhas an antibacterial spectrumthat is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. a various Grampositive organisms such as Corynebacterium spp.Tilmicosin Solution is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Crossresistance between tilmicosin and other macrolide antibiotics has been observed.Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.Tilmicosin Oral is indicated for the control and treatment of respiratory infections associated
with tilmicosin-susceptible micro-organisms such as Mycoplasma spp.
Description:
Tilmicosin Solution is a broadspectrum semisynthetic bactericidal macrolide antibiotic synthesized from tylosin.It has an antibacterial spectrumthat is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. a various Grampositive organisms such as Corynebacterium spp. It is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Crossresistance between tilmicosin and other macrolide antibiotics has been observed.Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.
Composition
Contains per ml: Tilmicosin(as tilmicosin phosphate) 300mg
Solvents ad 1ml
This Oral is indicated for the control and treatment of respiratory infections associated with tilmicosin-susceptible micro-organisms such as Mycoplasma spp.
Pasteurella multocida, Actinobacillus pleuropneumoniae, Actinomyces pyogenes and Mannheimia haemolytica in calves, chickens, turkeys and swine.
Indications
Contra indications
Hypersensitivity or resistance to tilmicosin.
Concurrent administration of other macrolides or lincosamides.
Administration to animals with an active microbial digestion or to equine or caprine species.
Parenteral administration, especially in porcine species.
Administration to poultry producing eggs for human consumption or to animals intended for breeding purposes. During pregnancy and lactation, use only after a risk/benefit assessment by a veterinarian.
Side effects
Occasionally, a transient reduction in water or (artificial) milk intake has been observed upon treatment with tilmicosin.
Dosage
For oral administration
Calves: Twice daily, 1ml per 25 kg boy weight via (artificial)milk for 3-5 days.
Poultry: 250ml per 1000liters of drinking water(75 ppm) for 3 days.
Poultry: 700ml per 1000liters of drinking water(200 ppm) for 5 days.
Withdrawal timesNote:
Medicated drinking water or (artificial) milk should be prepared fresh every 24 h. To ensure a correct dosage, the concentration of the product should be adjusted to the actual fluid intake.
|
- For meat:
|
|
Calves
|
:
|
42 days.
|
|
Broilers
|
:
|
12 days.
|
|
Turkeys
|
:
|
19 days.
|
|
Swine
|
:
|
14 days.
|
Warning
Keep out of reach of children.
Packing
Bottle of 500 and 1000 ml.
Contact Now
